CELAC and European consortium for a personalized medicine approach to Gastric Cancer (LEGACy)
Recruiting
- Conditions
- Gastric cancerstomach cancer1001799010004018
- Registration Number
- NL-OMON48300
- Lead Sponsor
- Fundación para la investigación del hospital clínico de la comunidad Valenciana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
Subjects >18 years old from IPATIMUP, INCAN, VUMC, PUC, VHIO, IAF, INCLIVA and
GENPAT centres.
Has given and signed the IC to participate in this study.
With a gastroscopy indication due to the high diagnostic suspicion of GC as
part of the study of the disease and PT-INR/PTT <1.5 x ULN, unless coumarin
derivatives are used
Proven H. Pylori infection (only for legacy study 3)
Exclusion Criteria
Patients diagnosed with GC from other centres/ countries not participating in
this proposal.
Subjects from a different geographic area from the cases
Patients unable to give IC
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary aim of the LEGACY project is to improve GC outcomes by applying<br /><br>personalized medicine at the three levels of prevention in EU and CELAC<br /><br>populations participating in this Project based on an *omics integrative<br /><br>epidemiology* conceptual model as a strategy to be extended worldwide.</p><br>
- Secondary Outcome Measures
Name Time Method